Connection

Charles Bennett to Hematopoietic Stem Cell Transplantation

This is a "connection" page, showing publications Charles Bennett has written about Hematopoietic Stem Cell Transplantation.
  1. Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant. 2016 Feb; 51(2):277-82.
    View in: PubMed
    Score: 0.419
  2. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999 Sep; 24(5):555-60.
    View in: PubMed
    Score: 0.137
  3. A review of the costs, cost-effectiveness and third-party charges of bone marrow transplantation. Stem Cells. 1996 May; 14(3):312-9.
    View in: PubMed
    Score: 0.108
  4. Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Sep; 51(9):1228-32.
    View in: PubMed
    Score: 0.108
  5. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007 Aug; 40(3):185-92.
    View in: PubMed
    Score: 0.059
  6. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007 Apr; 39(7):425-9.
    View in: PubMed
    Score: 0.057
  7. Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplant. 1999 Sep; 24(6):679-84.
    View in: PubMed
    Score: 0.034
  8. Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know? Bone Marrow Transplant. 1998 Apr; 21(7):641-50.
    View in: PubMed
    Score: 0.031
  9. Economic analyses of new technologies: the case of stem-cell transplantation. J Clin Oncol. 1997 Jan; 15(1):2-4.
    View in: PubMed
    Score: 0.028
  10. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991. J Clin Oncol. 1995 Apr; 13(4):969-73.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.